Related Experiment Video
Updated: May 12, 2026
07:49
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
Delayed-release prednisone - a new approach to an old therapy
Frank Buttgereit1, Allan Gibofsky
1Charité University Medicine, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany. frank.buttgereit@charite.de
Expert Opinion on Pharmacotherapy
|April 19, 2013
Summary
Delayed-release prednisone, taken at bedtime, improves morning stiffness in inflammatory conditions like rheumatoid arthritis. This advanced formulation enhances efficacy while maintaining a similar safety profile to conventional treatments.
Area of Science:
- Pharmacology
- Rheumatology
- Immunology
Background:
- Glucocorticoids (GCs) are widely used for inflammatory conditions but require optimized use for better efficacy and reduced side effects.
- Delayed-release prednisone represents an advanced, clinically available formulation for GC therapy.
- There is a need to improve the benefit:risk ratio of GC treatment in inflammatory diseases.
Purpose of the Study:
- To evaluate the efficacy and safety of delayed-release prednisone in managing inflammatory conditions with circadian features.
- To compare delayed-release prednisone with conventional immediate-release prednisone and placebo.
- To explore the potential benefits of delayed-release prednisone in conditions beyond rheumatoid arthritis.
Main Methods:
- Delayed-release prednisone (1-5 mg) administered at bedtime with a 4-6 hour lag time before drug release.
- Clinical trials conducted in patients with rheumatoid arthritis (RA).
- Comparison of delayed-release prednisone against immediate-release prednisone and placebo in RA patients on disease-modifying antirheumatic drugs.
Main Results:
- Delayed-release prednisone significantly improved morning stiffness in RA patients compared to immediate-release prednisone and placebo.
- The incidence of adverse events with delayed-release prednisone was comparable to the comparator groups.
- Preliminary studies indicate potential benefits in polymyalgia rheumatica and asthma.
Conclusions:
- Delayed-release prednisone offers an effective strategy to enhance the benefit:risk profile of GC therapy.
- This formulation is particularly beneficial for inflammatory conditions exhibiting circadian patterns in symptoms.
- Optimized GC delivery through delayed-release prednisone holds promise for improving patient outcomes in various inflammatory diseases.
Related Concept Videos
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...